A patient is experiencing thrombocytopenia and needs a blood product to increase their platelet count.
Which blood product should the nurse administer to address this condition?
Whole blood.
Packed red blood cells (PRBCs)
Fresh frozen plasma (FFP)
Platelets.
The Correct Answer is D
Choice A rationale:
Whole blood.
Rationale: Whole blood contains red blood cells, plasma, platelets, and other components.
It is typically used for patients with significant blood loss or when multiple blood components need to be replaced.
However, in this case, the patient is specifically experiencing thrombocytopenia, which means a low platelet count.
Administering whole blood would not be the most appropriate choice because it does not provide a concentrated dose of platelets, which is what the patient needs.
Choice B rationale:
Packed red blood cells (PRBCs)
Rationale: Packed red blood cells are primarily used to increase oxygen-carrying capacity in patients with anemia or significant blood loss.
They do not contain a sufficient quantity of platelets to address thrombocytopenia, so this is not the correct choice for the patient in question.
Choice C rationale:
Fresh frozen plasma (FFP)
Rationale: Fresh frozen plasma is rich in clotting factors and is used to treat bleeding disorders or clotting factor deficiencies.
While it can be a valuable component in some cases, it does not directly increase platelet counts.
Therefore, it is not the most appropriate choice for a patient with thrombocytopenia.
Choice D rationale:
Platelets.
Rationale: Platelets are the correct choice for a patient with thrombocytopenia.
Platelet transfusion provides a concentrated dose of platelets, which can help increase the patient's platelet count and improve clotting ability.
It directly addresses the underlying issue in thrombocytopenia, making it the most suitable option.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["A","C"]
Explanation
Choice A rationale:
Fever is a potential sign of a delayed transfusion reaction.
Delayed transfusion reactions can occur several days after a blood transfusion and may present with fever as a symptom.
This can be indicative of hemolysis or an immune response to the transfused blood.
Choice C rationale:
Jaundice is another sign that the nurse should monitor for delayed transfusion reactions.
Jaundice can be a result of hemolysis, where the red blood cells are destroyed, leading to an increase in bilirubin levels in the bloodstream.
Choice B rationale:
Increased urine output is not typically associated with delayed transfusion reactions.
Delayed reactions are more likely to manifest as fever, jaundice, or other signs of hemolysis.
Choice D rationale:
Hypertension is not a common sign of delayed transfusion reactions.
These reactions are more likely to present with symptoms related to the destruction of red blood cells, such as fever and jaundice.
Choice E rationale:
Decreased oxygen saturation is not a typical sign of delayed transfusion reactions.
It is important to monitor oxygen saturation during a blood transfusion, but this is more relevant to immediate transfusion reactions, such as transfusion-related acute lung injury (TRALI)
Correct Answer is ["A","C","D"]
Explanation
Choice A rationale:
Normal saline is a sterile solution of sodium chloride in water, and it is a commonly used intravenous fluid to expand blood volume.
It is isotonic, meaning it has a similar osmolarity to blood, and can effectively increase circulating blood volume without adding blood cells.
Choice C rationale:
Albumin is a colloid solution often used as a volume expander.
It contains proteins that help maintain colloid osmotic pressure, which can draw fluid from interstitial spaces into the bloodstream, thereby increasing blood volume and circulation without adding blood cells.
Choice D rationale:
Hydroxyethyl starch (HES) is another colloid solution used as a volume expander.
It works similarly to albumin by increasing colloid osmotic pressure and attracting fluid into the vascular space, thereby increasing blood volume and circulation without adding blood cells.
Choice B rationale:
Erythropoietin (EPO) is a hormone that stimulates the production of red blood cells in the bone marrow.
It does not directly increase blood volume or circulation; instead, it increases the number of red blood cells, which can improve oxygen-carrying capacity in the long term but does not serve as a volume expander.
Choice E rationale:
Oxygen therapy is not a volume expander.
While it can increase the oxygen-carrying capacity of the blood by providing supplemental oxygen, it does not increase blood volume or circulation and is not used for that purpose.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.